Markwell Clarizio LLP

Team Members

Rebecca Crane

Rebecca Crane, Ph.D.*

Rebecca is a drug regulatory and patent litigation lawyer who applies her legal and scientific expertise to strategically advise and support clients.
Rebecca was called to the bar in 2006 and has spent her entire career working in national and global law firms working on pharmaceutical and biotechnology cases. Rebecca also obtained a Ph.D. in microbiology from the University of Guelph. Rebecca’s Ph.D. dissertation focused on the purification and characterization of osmoregulatory proteins of Escherichia coli. She has significant research experience in biochemistry, molecular biology, and microbiology. Prior to joining Markwell Clarizio LLP, Rebecca practised at several international law firms.
Rebecca’s legal and scientific background allows her to uniquely understand clients’ technology, business objectives, and product portfolios in support of their patent litigation and regulatory matters.
Rebecca frequently represents life sciences and pharmaceutical industry clients in patent litigation matters and strategic product regulatory advice, including on matters related to Canada’s Patented Medicines Prices Review Board (PMPRB).
Rebecca has been recognized as a leading lawyer in her field by various independent publications including IAM Patent 1000, The Best Lawyers Canada, and IP Stars. She has co-authored a number of scientific and legal publications, including in the AUTM Journal, Biochemistry, Journal of Bacteriology, and the Food and Drug Law Institute Update.

Rebecca is a member of the Toronto Intellectual Property Group (TIPG), the Intellectual Property Institute of Canada (IPIC), the Law Society of Ontario (LSO), the Ontario Bar Association (OBA) and the Canadian Bar Association (CBA).